Published 1 month ago

Cybin Inc (CYBN) Stock Forecast 2024

Summary by Ground News

Cybin Inc. (CYBN) is a Canadian biopharmaceutical company focused on the development of psychedelic-based therapeutics for mental health disorders. CYBN is developing CYB003 for the treatment of major depressive disorder (MDD) and will be sharing results from their Phase 2 trial, including data on how long the treatment effects last (4-month durability)

0 Articles

All

Left

Center

Right

CrowdWisdom360

Cybin Inc (CYBN) Stock Forecast 2024

CYBN Stock Forecast 2024: Latest Price Track all markets on TradingView Article Coverage: CYBN Stock The post Cybin Inc (CYBN) Stock Forecast 2024 appeared first on Crowdwisdom360.

1 month ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated1 month agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Cybin Inc (CYBN) Stock Forecast 2024

0 Articles

0 Articles

Cybin Inc (CYBN) Stock Forecast 2024

Cybin Inc (CYBN) Stock Forecast 2024

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics